A comprehensive industry depth analysis report on China's pharmaceutical intermediates sector was released in October 2023. The report delves extensively into the current market status, production volume, scale, competitive landscape, and development trends of the industry. It highlights that, as of the time of publication, there were a total of 21,217 major enterprises operating within the domestic pharmaceutical intermediates sector. The peak number of registered enterprises was reached in 2019, amounting to 1,960. In 2021, there were 315 new registrations, indicating that the industry continues to maintain a certain level of growth momentum.